N-(biphenylmethyl)-3-hydroxyglutaramic acid and derivatives as hypocholesterolemic agents
US5169976A · kind A · utility
1Cited by
8References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 3, 1990 |
| Grant date | Dec 8, 1992 |
| Priority date | — |
| Expiry date | May 3, 2010 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/1804
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Variously substituted 4-(biphen-2-ylmethylcarbamoyl)-3-hydroxybutyric acids and esters, also named as N-(biphen-2-yl)-3-hydroxyglutaramic acid derivatives, are blood cholesterol lowering agents and so are useful in the prevention and treatment of cardiovascular diseases such as atherosclerosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.